Oversubscribed Fund Exceeds Target by 25 Percent Commitments Secured From Over 30 Investors Including PSERS Already Led Three Initial Investments AUSTIN, Texas, May 29, 2019-- Santé Ventures, a healthcare and life sciences investment firm specializing in early-stage companies developing innovative new medical technologies, biotechnologies, digital health technologies, and healthcare services, announced today the final close of its oversubscribed Fund III. Almost twice as large as its predecessor, Fund III secured capital commitments from over 30 limited partners, including the previously announced new investor, Pennsylvania Public School Employees' Retirement System ("PSERS").